Veterinary eye care market size is estimated to grow by USD 788.78 million from 2021 to 2026, Market is driven by rising pet ownership- Technavio
NEW YORK, Dec. 7, 2022 /PRNewswire/ -- The veterinary eye care market size is estimated to grow by USD 788.78 million from 2021 to 2026 at a CAGR of 4.65% according to Technavio. The rising pet ownership is notably driving the veterinary eye care services market growth. However, factors such as the stringent regulatory approval process of drugs may impede the market growth.
The information services market report provides critical information and factual data, with a qualitative and quantitative study of the market based on market drivers and limitations as well as future prospects.
The rising awareness about pet insurance is a primary trend for the veterinary eye care market growth.
The higher adoptions of pet insurance are due to favorable pet insurance policies and will fuel the growth of the global veterinary eye care market during the forecast period.
Countries such as the US and Canada are adopting health insurance policies for pets, which can help them cover the medical expenses of their pets. The demand for pet insurance has also increased in parts of Asia.
The growing popularity of pet insurance should help owners avail proper medical treatment, which will drive the growth of the global veterinary eye care market.
Drivers, trends, and challenges have an impact on market dynamics, which can impact businesses. Find more insights in a sample report!
Veterinary eye care Services Market: Key Vendors
Bausch Health Co Inc
Akorn Operating Co. LLC
Animal HealthQuest
Beaphar Beheer BV
Central Garden and Pet Co.
Epicur Pharma
I MED Pharma Inc.
Innovacyn Inc.
Manna Pro Products LLC
Menicon Co. Ltd.
MiracleCorp Products
TVM UK Animal Health Ltd.
Zoetis Inc.
Veterinary eye care Services Market: Segmentation Analysis
Application Outlook (Revenue, USD million, 2021-2026)
Dogs - size and forecast 2021-2026
Cats - size, and forecast 2021-2026
Others - size and forecast 2021-2026
Geography Outlook (Revenue, USD million, 2021-2026)
Veterinary CRO Market by Type and Geography - Forecast and Analysis 2022-2026: The Veterinary CRO market size is forecasted to grow by USD 277.21 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 7.75%. Furthermore, this report extensively covers market segmentation by type (clinical trials, toxicology, and market authorization and regulatory support) and geography (North America, Europe, Asia, and Rest of World (ROW)).
Animal Pregnancy Test Kit Market by product, and Geography - Forecast and Analysis 2023-2027: The animal pregnancy test kit market is estimated to grow at a CAGR of 4.76% between 2022 and 2027. The size of the market is forecast to grow by USD 98.33 million. This report extensively covers market segmentation by product (cassettes, strips, and enzyme-linked immunoassay), and geography (North America, Europe, Asia, and Rest of World (ROW)).
Veterinary eye care Services Market Scope
Report Coverage
Details
Page number
117
Base year
2021
Forecast period
2022-2026
Growth momentum & CAGR
Accelerate at a CAGR of 4.65%
Market growth 2022-2026
USD 788.78 million
Market structure
Fragmented
YoY growth 2021-2022 (%)
4.3
Regional analysis
North America, Europe, APAC, and Rest of World (ROW)
Performing market contribution
North America at 39%
Key countries
US, China, Germany, UK, and France
Competitive landscape
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks
Key companies profiled
Bausch Health Co Inc, Akorn Operating Co. LLC, Animal HealthQuest, Beaphar Beheer BV, Central Garden and Pet Co., Epicur Pharma, I MED Pharma Inc., Innovacyn Inc., Manna Pro Products LLC, Menicon Co. Ltd., MiracleCorp Products, TVM UK Animal Health Ltd., and Zoetis Inc.
Market dynamics
Parent Market Analysis; Market growth inducers and obstacles; Fast-growing and slow-growing segment analysis for the forecast period.
Customization purview
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.
Exhibit 93: Animal HealthQuest - Product / Service
Exhibit 94: Animal HealthQuest - Key offerings
10.5 Bausch Health Co Inc
Exhibit 95: Bausch Health Co Inc - Overview
Exhibit 96: Bausch Health Co Inc - Business segments
Exhibit 97: Bausch Health Co Inc - Key news
Exhibit 98: Bausch Health Co Inc - Key offerings
Exhibit 99: Bausch Health Co Inc - Segment focus
10.6 Epicur Pharma
Exhibit 100: Epicur Pharma - Overview
Exhibit 101: Epicur Pharma - Product / Service
Exhibit 102: Epicur Pharma - Key offerings
10.7 I MED Pharma Inc.
Exhibit 103: I MED Pharma Inc. - Overview
Exhibit 104: I MED Pharma Inc. - Product / Service
Exhibit 105: I MED Pharma Inc. - Key offerings
10.8 Innovacyn Inc.
Exhibit 106: Innovacyn Inc. - Overview
Exhibit 107: Innovacyn Inc. - Product / Service
Exhibit 108: Innovacyn Inc. - Key offerings
10.9 Manna Pro Products LLC
Exhibit 109: Manna Pro Products LLC - Overview
Exhibit 110: Manna Pro Products LLC - Product / Service
Exhibit 111: Manna Pro Products LLC - Key offerings
10.10 Menicon Co. Ltd.
Exhibit 112: Menicon Co. Ltd. - Overview
Exhibit 113: Menicon Co. Ltd. - Product / Service
Exhibit 114: Menicon Co. Ltd. - Key news
Exhibit 115: Menicon Co. Ltd. - Key offerings
10.11 MiracleCorp Products
Exhibit 116: MiracleCorp Products - Overview
Exhibit 117: MiracleCorp Products - Product / Service
Exhibit 118: MiracleCorp Products - Key offerings
10.12 Zoetis Inc.
Exhibit 119: Zoetis Inc. - Overview
Exhibit 120: Zoetis Inc. - Business segments
Exhibit 121: Zoetis Inc. - Key news
Exhibit 122: Zoetis Inc. - Key offerings
Exhibit 123: Zoetis Inc. - Segment focus
11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 124: Inclusions checklist
Exhibit 125: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 126: Currency conversion rates for US$
11.4 Research methodology
Exhibit 127: Research methodology
Exhibit 128: Validation techniques employed for market sizing
Exhibit 129: Information sources
11.5 List of abbreviations
Exhibit 130: List of abbreviations
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community. Aspire Health experienced a data security incident that may have involved personal and...